-transparent.png){kind=logo}
Diclofenac is a potent anti-inflammatory and analgesic compound with good antipyretic and uricosuric properties. It is one of the most potent inhibitors of prostaglandin synthetase known. It shows a favourable therapeutic ratio considering its efficacy, and proved superior to the reference drugs in terms of gastro-intestinal tolerability. All metabolites are clearly less potent than the parent compound.
Related Publications
R Maier, and
R Menassé, and
L Riesterer, and
C Pericin, and
M Ruegg, and
R Ziel
January 1979,
Rheumatology and rehabilitation,
R Maier, and
R Menassé, and
L Riesterer, and
C Pericin, and
M Ruegg, and
R Ziel
January 1979,
Rheumatology and rehabilitation,
R Maier, and
R Menassé, and
L Riesterer, and
C Pericin, and
M Ruegg, and
R Ziel
January 1979,
Rheumatology and rehabilitation,
R Maier, and
R Menassé, and
L Riesterer, and
C Pericin, and
M Ruegg, and
R Ziel
January 1979,
Rheumatology and rehabilitation,
R Maier, and
R Menassé, and
L Riesterer, and
C Pericin, and
M Ruegg, and
R Ziel
January 1979,
Rheumatology and rehabilitation,
R Maier, and
R Menassé, and
L Riesterer, and
C Pericin, and
M Ruegg, and
R Ziel
January 1979,
Rheumatology and rehabilitation,
R Maier, and
R Menassé, and
L Riesterer, and
C Pericin, and
M Ruegg, and
R Ziel
April 1986,
The American journal of medicine,
R Maier, and
R Menassé, and
L Riesterer, and
C Pericin, and
M Ruegg, and
R Ziel
January 1979,
Rheumatology and rehabilitation,
R Maier, and
R Menassé, and
L Riesterer, and
C Pericin, and
M Ruegg, and
R Ziel
November 1985,
Seminars in arthritis and rheumatism,
R Maier, and
R Menassé, and
L Riesterer, and
C Pericin, and
M Ruegg, and
R Ziel
January 1979,
Rheumatology and rehabilitation,
